Long non-coding rnas differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Reiche, Kristin ^a,b   Kasack, Katharina ^b,c   Schreiber, Stephan ^a,b   Lüders, Torben ^d,e   Due, Eldri U ^e,f   Naume, Bjørn ^e,f   Riis, Margit ^g   Kristensen, Vessela N ^d,e,f   Horn, Friedemann ^b,c   Børresen Dale, Anne Lise ^e,f   Hackermüller, Jörg ^a,b   Baumbusch, Lars O ^f  

^a HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^b FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^e Department of International Studies and Interpreting   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; HISTONE DEACETYLASE 3; LONG UNTRANSLATED RNA; MESSENGER RNA; TRANSCRIPTION FACTOR; CHROMATIN; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BREAST CANCER; CANCER RELATED PROTEIN CODING GENE; CANCER TISSUE; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN TISSUE; INTRON; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIMARY TUMOR; PROMOTER REGION; TUMOR GENE; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMATIN; FEMALE; HUMANS; NEOPLASM PROTEINS; RNA, LONG NONCODING; TRANSCRIPTION, GENETIC;

EID: 84907522363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106076     Document Type: Article

References (97)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30
2. Perou C, Sørlie T, Eisen M, van de RM, Jeffrey S, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752
3. Sørlie T, Perou C, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874
4. Network CGA (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70
5. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, et al. (2012) Landscape of transcription in human cells. Nature 489: 101-108
6. Clark MB, Amaral PP, Schlesinger FJ, Dinger ME, Taft RJ, et al. (2011) The reality of pervasive transcription. PLoS Biol 9: E1000625
7. Birney E, Stamatoyannopoulos J, Dutta A, Guigó R, Gingeras T, et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816
8. Jacob F, Monod J (1961) Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol 3: 318-356
9. Nagano T, Fraser P (2009) Emerging similarities in epigenetic gene silencing by long noncoding RNAs. Mamm Genome 20: 557-562
10. Clark MB, Mattick JS (2011) Long noncoding RNAs in cell biology. Semin Cell Dev Biol 22: 366-376
11. Mercer T, Dinger M, Mattick J (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10: 155-159
12. Guttman M, Rinn JL (2012) Modular regulatory principles of large non-coding rnas. Nature 482: 339-346
13. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, et al. (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472: 120-124
14. Ørom U, Derrien T, Beringer M, Gumireddy K, Gardini A, et al. (2010) Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46-58
15. Feng J, Bi C, Clark BS, Mady R, Shah P, et al. (2006) The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev 20: 1470-1484
16. Martianov I, Ramadass A, Barros AS, Chow N, Akoulitchev A (2007) Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 445: 666-670
17. Wang J, Liu X, Wu H, Ni P, Gu Z, et al. (2010) CREB up-regulates long noncoding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 38: 5366-5383
18. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, et al. (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495: 384-388
19. Gutschner T, Diederichs S (2012) The hallmarks of cancer: A long non-coding RNA point of view. RNA Biol 9: 703-719
20. Ank ML, Neugebauer KM (2010) Long noncoding RNAs add another layer to pre-mRNA splicing regulation. Mol Cell 39: 833-834
21. Guttman M, Amit I, Garber M, French C, Lin M, et al. (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-227
22. Khalil A, Guttman M, Huarte M, Garber M, Raj A, et al. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106: 11667-11672
23. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, et al. (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25: 1915-1927
24. Tsai M, Manor O, Wan Y, Mosammaparast N, Wang J, et al. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693
25. Gupta R, Shah N, Wang K, Kim J, Horlings H, et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076
26. Magistri M, Faghihi MA, St Laurent G 3rd, Wahlestedt C (2012) Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet 28: 389-396
27. Mondal T, Rasmussen M, Pandey GK, Isaksson A, Kanduri C (2010) Characterization of the RNA content of chromatin. Genome Res 20: 899-907
28. Enerly E, Steinfeld I, Kleivi K, Leivonen S, Aure M, et al. (2011) miRNAmRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 6: E16915
29. Dvinge H, Git A, Gräf S, Salmon-Divon M, Curtis C, et al. (2013) The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497: 378-382
30. Gibb EA, Brown CJ, Lam WL (2011) The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10: 38
31. Prensner JR, Chinnaiyan AM (2011) The emergence of lncRNAs in cancer biology. Cancer Discov 1: 391-407
32. Qiu MT, Hu JW, Yin R, Xu L (2013) Long noncoding RNA: An emerging paradigm of cancer research. Tumour Biol 34: 613-620
33. Huarte M, Rinn J (2010) Large non-coding RNAs: missing links in cancer? Hum Mol Genet 19: R152-R161
34. Shore AN, Herschkowitz JI, Rosen JM (2012) Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go. J Mammary Gland Biol Neoplasia 17: 43-58
35. Jiang Z, Zhou Y, Devarajan K, Slater CM, Daly MB, et al. (2012) Identifying putative breast cancer-associated long intergenic non-coding RNA loci by high density SNP array analysis. Front Genet 3: 299
36. Piao HL, Ma L (2012) Non-coding RNAs as regulators of mammary development and breast cancer. J Mammary Gland Biol Neoplasia 17: 33-42
37. Shi Y, Lu J, Zhou J, Tan X, He Y, et al. (2014) Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells. Biochem Biophys Res Commun 446: 448-453
38. Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, et al. (2013) CCAT2, a novel long noncoding RNA in breast cancer: Expression study and clinical correlations. Oncotarget: in press
39. Berteaux N, Lottin S, Monté D, Pinte S, Quatannens B, et al. (2005) H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem 280: 29625-29636
40. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT (2009) GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28: 195-208
41. Maruyama R, Shipitsin M, Choudhury S, Wu Z, Protopopov A, et al. (2012) Altered antisense-to-sense transcript ratios in breast cancer. Proc Natl Acad Sci U S A 109: 2820-2824
42. Guffanti A, Iacono M, Pelucchi P, Kim N, Sold G, et al. (2009) A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 10: 163
43. Hackermüller J, Reiche K, Otto C, Hösler N, Blumert C, et al. (2014) Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein coding RNAs. Genome Biol 15: R48
44. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes E, et al. (2007) Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Molecular Oncology 1: 160-171
45. Nielsen T, Parker J, Leung S, Voduc D, Ebbert M, et al. (2010) A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin Cancer Res 16: 5222-5232
46. Washietl S, Findeiss S, Müller S, Kalkhof S, von BM, et al. (2011) RNAcode: Robust discrimination of coding and noncoding regions in comparative sequence data. RNA 17: 578-594
47. Pruitt KD, Tatusova T, Maglott DR (2007) NCBI reference sequences (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 35: D61-D65
48. Zhao M, Sun J, Zhao Z (2013) TSGene: A web resource for tumor suppressor genes. Nucleic Acids Res 41: D970-D976
49. Aure MR, Steinfeld I, Baumbusch LO, Liestøl K, Lipson D, et al. (2013) Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data. PLoS ONE 8: E53014
50. Pollack J, Sørlie T, Perou C, Rees C, Jeffrey S, et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99: 12963-12968
51. Amaral P, Clark M, Gascoigne D, Dinger M, Mattick J (2011) lncRNAdb: A reference database for long noncoding RNAs. Nucleic Acids Res 39: D146-D151
52. Nakaya HI, Amaral PP, Louro R, Lopes A, Fachel AA, et al. (2007) Genome mapping and expression analyses of human intronic noncoding RNAs reveal tissue-specific patterns and enrichment in genes related to regulation of transcription. Genome Biol 8: R43
53. Gesell T, Washietl S (2008) Dinucleotide controlled null models for comparative RNA gene prediction. BMC Bioinformatics 9: 248
54. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, et al. (2009) An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell 33: 717-726
55. Zhou Y, Zhang X, Klibanski A (2012) MEG3 noncoding RNA: A tumor suppressor. J Mol Endocrinol 48: R45-R53
56. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, et al. (2012) The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res 22: 1775-1789
57. Smith MA, Gesell T, Stadler PF, Mattick JS (2013) Widespread purifying selection on RNA structure in mammals. Nucleic Acids Res 41: 8220-8236
58. Gruber AR, Findeiss S, Washietl S, Hofacker IL, Stadler PF (2010) RNAz 2.0: Improved noncoding RNA detection. Pac Symp Biocomput 15: 69-79
59. Pedersen JS, Bejerano G, Siepel A, Rosenbloom K, Lindblad-Toh K, et al. (2006) Identification and classification of conserved RNA secondary structures in the human genome. PLoS Comput Biol 2: E33
60. Washietl S, Pedersen JS, Korbel JO, Stocsits C, Gruber AR, et al. (2007) Structured RNAs in the ENCODE selected regions of the human genome. Genome Res 17: 852-864
61. Guil S, Esteller M (2012) Cis-acting noncoding RNAs: friends and foes. Nat Struct Mol Biol 19: 1068-1075
62. Maamar H, Cabili MN, Rinn J, Raj A (2013) linc-HOXA1 is a noncoding RNA that represses Hoxa1 transcription in cis. Genes Dev 27: 1260-1271
63. Russnes HG, Vollan HKM, Lingjærde OC, Krasnitz A, Lundin P, et al. (2010) Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci Transl Med 2: 38ra47
64. Bergamaschi A, Kim YH, Wang P, Srlie T, Hernandez-Boussard T, et al. (2006) Distinct patterns of dna copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 45: 1033-1040
65. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541
66. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352
67. Kawakami T, Zhang C, Taniguchi T, Kim CJ, Okada Y, et al. (2004) Characterization of loss-of-inactive X in Klinefelter syndrome and femalederived cancer cells. Oncogene 23: 6163-6169
68. Benoît MH, Hudson TJ, Maire G, Squire JA, Arcand SL, et al. (2007) Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Int J Oncol 30: 5-17
69. Berteaux N, Aptel N, Cathala G, Genton C, Coll J, et al. (2008) A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression. Mol Cell Biol 28: 6731-6745
70. Lu L, Zhu G, Zhang C, Deng Q, Katsaros D, et al. (2012) Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res Treat 136: 875-883
71. Santa FD, Barozzi I, Mietton F, Ghisletti S, Polletti S, et al. (2010) A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 8: E1000384
72. Kanhere A, Viiri K, Arajo CC, Rasaiyaah J, Bouwman RD, et al. (2010) Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol Cell 38: 675-688
73. Ebisuya M, Yamamoto T, Nakajima M, Nishida E (2008) Ripples from neighbouring transcription. Nat Cell Biol 10: 1106-1113
74. Lai F, Ørom UA, Cesaroni M, Beringer M, Taatjes DJ, et al. (2013) Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 494: 497-501
75. Nakagawa M, Oda Y, Eguchi T, Aishima SI, Yao T, et al. (2007) Expression profile of class I histone deacetylases in human cancer tissues. Oncol Rep 18: 769-774
76. Kim HC, Choi KC, Choi HK, Kang HB, Kim MJ, et al. (2010) HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells. Cell Mol Life Sci 67: 3499-3510
77. Cui Wj, Liu Y, Zhou Xl, Wang Fz, Zhang Xd, et al. (2010) Myosin light chain kinase is responsible for high proliferative ability of breast cancer cells via antiapoptosis involving p38 pathway. Acta Pharmacol Sin 31: 725-732
78. Caldwell SA, Jackson SR, Shahriari KS, Lynch TP, Sethi G, et al. (2010) Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29: 2831-2842
79. Peng L, Yanjiao M, Ai-guo W, Pengtao G, Jianhua L, et al. (2011) A fine balance between CCNL1 and TIMP1 contributes to the development of breast cancer cells. Biochem Biophys Res Commun 409: 344-349
80. Wiedswang G, Borgen E, Kresen R, Kvalheim G, Nesland J, et al. (2003) Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 21: 3469-3478
81. Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, et al. (2011) Combining gene signatures improves prediction of breast cancer survival. PLoS One 6: E17845
82. R Core Team (2012) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available: http://www.R-project.org. ISBN 3-900051-07-0
83. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3
84. Kent WJ (2002) BLAT-the BLAST-like alignment tool. Genome Res 12: 656-664
85. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193
86. Benjamini Y, Hochberg Y (1995) Controlling false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society B 57: 289-300
87. Nordgard SH, Johansen FE, Alnæs GIG, Bucher E, Syvänen AC, et al. (2008) Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes Chromosomes Cancer 47: 680-696
88. Lingjærde O, Baumbusch L, Liestøl K, Glad I, Børresen-Dale A (2005) CGHExplorer: A program for analysis of array-CGH data. Bioinformatics 21: 821-822
89. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, et al. (2012) GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22: 1760-1774
90. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, et al. (2013) The UCSC genome browser database: Extensions and updates 2013. Nucleic Acids Res: D64-9
91. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, et al. (2002) The Ensembl genome database project. Nucleic Acids Res 30: 38-41
92. Blanchette M, Kent WJ, Riemer C, Elnitski L, Smit AFA, et al. (2004) Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res 14: 708-715
93. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, et al. (2009) BLAST+: Architecture and applications. BMC Bioinformatics 10: 421
94. Gagneur J, Toedling J, Bourgon R, Delhomme N (2012) genomeIntervals: Operations on genomic intervals. R package version 1.14.0
95. Tierney L, Rossini AJ, Li N, Sevcikova H (2012) snow: Simple Network of Workstations. Available: http://CRAN.R-project.org/package=snow. R package version 0.3-10
96. Falcon S, Gentleman R (2007) Using GOstats to test gene lists for GO term association. Bioinformatics 23: 257-258
97. Washietl S, Hofacker IL, Lukasser M, Hüttenhofer A, Stadler PF (2005) Mapping of conserved RNA secondary structures predicts thousands of functional noncoding RNAs in the human genome. Nat Biotechnol 23: 1383-1390